{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T18:02:20Z","timestamp":1784916140493,"version":"3.55.0"},"reference-count":82,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Breast cancer (BC) remains the leading cause of cancer-related mortality among women globally. Precise subtyping of BC is critical for optimizing treatment strategies. This study explored the capacity of bulk RNA-seq data to improve breast cancer characterization by analysis of complete expression profiles. We analyzed RNA-seq data for 274 tumor samples and six healthy tissue samples from diverse geographical origins. Using over 9,800 SNPs directly genotyped from RNA-seq data, we successfully predicted broad genetic ancestry, identifying European, African, Asian, South Asian, and Admixed American origins. Molecular subtyping through PAM50 showed some level of ambiguity, depending on the amount of samples provided as input.\n                    <jats:italic>In silico<\/jats:italic>\n                    drug sensitivity analysis identified potential therapeutic strategies, including Etoposide and Mistaurin, with cluster-specific efficacy. Our findings emphasize the integration of ancestry-informed data and complete transcriptomic profiles to redefine BC subtyping. These insights offer a foundation for more equitable, ancestry-informed therapeutic strategies and highlight the importance of diversity in cancer research.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0352514","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:33:39Z","timestamp":1784914419000},"page":"e0352514","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Breast cancer clustering integrating complete gene expression profiles and genetic ancestry"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0107-8283","authenticated-orcid":true,"given":"Johanna","family":"Stepanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Mejia-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9105-6266","authenticated-orcid":true,"given":"Jorge","family":"Duitama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"3","key":"pone.0352514.ref001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"H Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"pone.0352514.ref002","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/cge.13900","article-title":"Molecular intrinsic versus clinical subtyping in breast cancer: a comprehensive review","volume":"99","author":"A Szymiczek","year":"2021","journal-title":"Clin Genet"},{"issue":"1","key":"pone.0352514.ref003","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.soc.2017.08.005","article-title":"Molecular subtypes and local-regional control of breast cancer","volume":"27","author":"SM Fragomeni","year":"2018","journal-title":"Surg Oncol Clin N Am"},{"issue":"5","key":"pone.0352514.ref004","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.surge.2016.10.001","article-title":"Prospective comparison of outcome after treatment for triple-negative and non-triple-negative breast cancer","volume":"15","author":"DP Joyce","year":"2017","journal-title":"Surgeon"},{"key":"pone.0352514.ref005","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.2147\/IJN.S113638","article-title":"Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel-cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines","volume":"11","author":"J Ye","year":"2016","journal-title":"Int J Nanomed"},{"issue":"9","key":"pone.0352514.ref006","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/cells8090957","article-title":"Mechanisms of chemotherapy resistance in triple-negative breast cancer-how we can rise to the challenge","volume":"8","author":"M Nedeljkovi\u0107","year":"2019","journal-title":"Cells"},{"issue":"6797","key":"pone.0352514.ref007","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"CM Perou","year":"2000","journal-title":"Nature"},{"issue":"2","key":"pone.0352514.ref008","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.breast.2013.01.016","article-title":"Gene expression profiling in breast cancer: a clinical perspective","volume":"22","author":"G Arpino","year":"2013","journal-title":"Breast"},{"issue":"3","key":"pone.0352514.ref009","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10549-013-2699-3","article-title":"The molecular diversity of Luminal A breast tumors","volume":"141","author":"G Ciriello","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"pone.0352514.ref010","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ctrv.2011.11.005","article-title":"Molecular biology in breast cancer: intrinsic subtypes and signaling pathways","volume":"38","author":"P Eroles","year":"2012","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"pone.0352514.ref011","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1158\/1055-9965.EPI-12-0474","article-title":"Impact of breast cancer subtypes and treatment on survival: an analysis spanning two decades","volume":"21","author":"R Haque","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"pone.0352514.ref012","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/bjs.9562","article-title":"Lessons learned from the intrinsic subtypes of breast cancer in the quest for precision therapy","volume":"101","author":"JH Norum","year":"2014","journal-title":"Br J Surg"},{"issue":"8","key":"pone.0352514.ref013","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011","volume":"22","author":"A Goldhirsch","year":"2011","journal-title":"Ann Oncol"},{"issue":"16","key":"pone.0352514.ref014","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1200\/JCO.2011.39.5624","article-title":"Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis","volume":"30","author":"M Ignatiadis","year":"2012","journal-title":"J Clin Oncol"},{"issue":"25","key":"pone.0352514.ref015","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1200\/JCO.2013.54.1870","article-title":"Luminal B breast cancer: molecular characterization, clinical management, and future perspectives","volume":"32","author":"F Ades","year":"2014","journal-title":"J Clin Oncol"},{"issue":"19","key":"pone.0352514.ref016","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/jnci\/djg050","article-title":"Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer","volume":"95","author":"WD Foulkes","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"pone.0352514.ref017","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3747\/co.23.3054","article-title":"Association between basal-like phenotype and BRCA1\/2 germline mutations in Korean breast cancer patients","volume":"23","author":"J Jung","year":"2016","journal-title":"Curr Oncol"},{"issue":"1","key":"pone.0352514.ref018","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/1055-9965.EPI-11-0775","article-title":"Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1\/2 (CIMBA)","volume":"21","author":"N Mavaddat","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"pone.0352514.ref019","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/156652412798376134","article-title":"Basal breast cancer: a complex and deadly molecular subtype","volume":"12","author":"F Bertucci","year":"2012","journal-title":"Curr Mol Med"},{"issue":"4","key":"pone.0352514.ref020","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.soc.2013.06.006","article-title":"Advances in molecular and clinical subtyping of breast cancer and their implications for therapy","volume":"22","author":"KA Cadoo","year":"2013","journal-title":"Surg Oncol Clin N Am"},{"key":"pone.0352514.ref021","article-title":"Clinical implications of the intrinsic molecular subtypes of breast cancer","author":"A Prat","year":"2015","journal-title":"Breast"},{"issue":"10","key":"pone.0352514.ref022","first-page":"2929","article-title":"Breast cancer intrinsic subtype classification, clinical use and future trends","volume":"5","author":"X Dai","year":"2015","journal-title":"Am J Cancer Res"},{"issue":"5","key":"pone.0352514.ref023","first-page":"1920","article-title":"PTEN loss is a predictive marker for HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies","volume":"24","author":"K Tekesin","year":"2019","journal-title":"J BUON"},{"issue":"2","key":"pone.0352514.ref024","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41416-020-01038-6","article-title":"Cancer health disparities in racial\/ethnic minorities in the United States","volume":"124","author":"VA Zavala","year":"2021","journal-title":"Br J Cancer"},{"issue":"9","key":"pone.0352514.ref025","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1158\/0008-5472.CAN-19-3659","article-title":"Human epidermal growth factor receptor 2-positive breast cancer is associated with indigenous American ancestry in Latin American women","volume":"80","author":"KM Marker","year":"2020","journal-title":"Cancer Res"},{"key":"pone.0352514.ref026","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/1471-2407-11-292","article-title":"Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study","volume":"11","author":"Y Su","year":"2011","journal-title":"BMC Cancer"},{"issue":"2","key":"pone.0352514.ref027","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10549-019-05325-6","article-title":"Associations between mammographic density and tumor characteristics in Chinese women with breast cancer","volume":"177","author":"E Li","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"pone.0352514.ref028","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.critrevonc.2009.09.002","article-title":"Variation in breast cancer subtypes with age and race\/ethnicity","volume":"76","author":"CA Parise","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"pone.0352514.ref029","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10549-010-1173-8","article-title":"Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry","volume":"127","author":"ML Telli","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"pone.0352514.ref030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20010","article-title":"Association of simulated patient race\/ethnicity with scheduling of primary care appointments","volume":"3","author":"JM Wisniewski","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"pone.0352514.ref031","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41523-021-00215-x","article-title":"Ancestry-associated transcriptomic profiles of breast cancer in patients of African, Arab, and European ancestry","volume":"7","author":"J Roelands","year":"2021","journal-title":"NPJ Breast Cancer"},{"issue":"11","key":"pone.0352514.ref032","first-page":"1481","article-title":"Clinicopathologic features of molecular subtypes of triple negative breast cancer based on immunohistochemical markers","volume":"27","author":"J Choi","year":"2012","journal-title":"Histol Histopathol"},{"key":"pone.0352514.ref033","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3389\/fonc.2020.00845","article-title":"Multi-omic regulation of the PAM50 gene signature in breast cancer molecular subtypes","volume":"10","author":"S Ochoa","year":"2020","journal-title":"Front Oncol"},{"key":"pone.0352514.ref034","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41523-019-0124-8","article-title":"Robust and interpretable PAM50 reclassification exhibits survival advantage for myoepithelial and immune phenotypes","volume":"5","author":"JC Mathews","year":"2019","journal-title":"NPJ Breast Cancer"},{"issue":"8","key":"pone.0352514.ref035","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"JS Parker","year":"2009","journal-title":"J Clin Oncol"},{"key":"pone.0352514.ref036","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12920-015-0129-6","article-title":"Development and verification of the PAM50-based Prosigna breast cancer gene signature assay","volume":"8","author":"B Wallden","year":"2015","journal-title":"BMC Med Genomics"},{"issue":"1","key":"pone.0352514.ref037","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41523-023-00589-0","article-title":"Perturbation and stability of PAM50 subtyping in population-based primary invasive breast cancer","volume":"9","author":"S Veerla","year":"2023","journal-title":"NPJ Breast Cancer"},{"issue":"2","key":"pone.0352514.ref038","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/annonc\/mdt494","article-title":"Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone","volume":"25","author":"M Gnant","year":"2014","journal-title":"Ann Oncol"},{"issue":"4","key":"pone.0352514.ref039","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/jamaoncol.2017.5524","article-title":"Comparison of the performance of 6 prognostic signatures for estrogen receptor-positive breast cancer: a secondary analysis of a randomized clinical trial","volume":"4","author":"I Sestak","year":"2018","journal-title":"JAMA Oncol"},{"issue":"5","key":"pone.0352514.ref040","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1634\/theoncologist.2007-0248","article-title":"Commercialized multigene predictors of clinical outcome for breast cancer","volume":"13","author":"JS Ross","year":"2008","journal-title":"Oncologist"},{"issue":"33","key":"pone.0352514.ref041","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1200\/JCO.2007.14.2364","article-title":"American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer","volume":"25","author":"L Harris","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"pone.0352514.ref042","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13058-021-01453-4","article-title":"Impact of Oncotype DX testing on ER+ breast cancer treatment and survival in the first decade of use","volume":"23","author":"E Schaafsma","year":"2021","journal-title":"Breast Cancer Res"},{"key":"pone.0352514.ref043","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1146\/annurev-genom-091416-035305","article-title":"Application of panel-based tests for inherited risk of cancer","volume":"18","author":"PD Shah","year":"2017","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"2","key":"pone.0352514.ref044","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/jnci\/djx135","article-title":"Racial differences in PAM50 subtypes in the Carolina breast cancer study","volume":"110","author":"MA Troester","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"pone.0352514.ref045","article-title":"Differences in 21-gene and PAM50 recurrence scores in younger and black women with breast cancer","volume":"8","author":"SC Van Alsten","year":"2024","journal-title":"JCO Precis Oncol"},{"issue":"5","key":"pone.0352514.ref046","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1158\/1055-9965.EPI-13-1023","article-title":"Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics","volume":"23","author":"C Sweeney","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"pone.0352514.ref047","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1001\/jamaoncol.2017.0595","article-title":"Comparison of breast cancer molecular features and survival by African and European ancestry in The Cancer Genome Atlas","volume":"3","author":"D Huo","year":"2017","journal-title":"JAMA Oncol"},{"issue":"23","key":"pone.0352514.ref048","doi-asserted-by":"crossref","first-page":"9723","DOI":"10.1158\/0008-5472.CAN-08-2039","article-title":"Genetic ancestry and risk of breast cancer among U.S. Latinas","volume":"68","author":"L Fejerman","year":"2008","journal-title":"Cancer Res"},{"issue":"10","key":"pone.0352514.ref049","article-title":"Breast cancer screening uptake among women from different ethnic groups in London: a population-based cohort study","volume":"4","author":"RH Jack","year":"2014","journal-title":"BMJ Open"},{"issue":"1","key":"pone.0352514.ref050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/bjc.2013.775","article-title":"Ethnic variation in breast cancer incidence and outcomes--the debate continues","volume":"110","author":"A Januszewski","year":"2014","journal-title":"Br J Cancer"},{"issue":"5","key":"pone.0352514.ref051","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju055","article-title":"US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status","volume":"106","author":"N Howlader","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"pone.0352514.ref052","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"D Aran","year":"2017","journal-title":"Genome Biol"},{"issue":"6","key":"pone.0352514.ref053","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/PAP.0000000000000416","article-title":"Update on the use of molecular subtyping in breast cancer","volume":"30","author":"TJ Lawton","year":"2023","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"pone.0352514.ref054","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1158\/0008-5472.CAN-22-0682","article-title":"Genetic ancestry inference from cancer-derived molecular data across genomic and transcriptomic platforms","volume":"83","author":"P Belleau","year":"2023","journal-title":"Cancer Res"},{"issue":"9","key":"pone.0352514.ref055","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1158\/1055-9965.EPI-25-0371","article-title":"An analytic pipeline to obtain reliable genetic ancestry estimates from tumor-derived RNA sequencing data","volume":"34","author":"CE Johnson","year":"2025","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"pone.0352514.ref056","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1261\/rna.070052.118","article-title":"Ancestry patterns inferred from massive RNA-seq data","volume":"25","author":"R Barral-Arca","year":"2019","journal-title":"RNA"},{"key":"pone.0352514.ref057","article-title":"Genotype prediction of 336,463 samples from public expression data","author":"A Razi","year":"2024","journal-title":"bioRxiv"},{"issue":"1","key":"pone.0352514.ref058","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/s42003-023-05171-9","article-title":"Direct inference and control of genetic population structure from RNA sequencing data","volume":"6","author":"M Fachrul","year":"2023","journal-title":"Commun Biol"},{"issue":"1","key":"pone.0352514.ref059","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13073-022-01019-9","article-title":"Clinical implementation of RNA sequencing for Mendelian disease diagnostics","volume":"14","author":"VA Y\u00e9pez","year":"2022","journal-title":"Genome Med"},{"issue":"6588","key":"pone.0352514.ref060","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.abj6987","article-title":"The complete sequence of a human genome","volume":"376","author":"S Nurk","year":"2022","journal-title":"Science"},{"issue":"7960","key":"pone.0352514.ref061","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41586-023-05896-x","article-title":"A draft human pangenome reference","volume":"617","author":"W-W Liao","year":"2023","journal-title":"Nature"},{"issue":"3","key":"pone.0352514.ref062","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/hmg\/ddac245","article-title":"Ethnic, gender and other sociodemographic biases in genome-wide association studies for the most burdensome non-communicable diseases: 2005-2022","volume":"32","author":"H Fitipaldi","year":"2023","journal-title":"Hum Mol Genet"},{"issue":"1","key":"pone.0352514.ref063","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s12864-024-10293-3","article-title":"Multi-trait GWAS for diverse ancestries: mapping the knowledge gap","volume":"25","author":"L Troubat","year":"2024","journal-title":"BMC Genomics"},{"key":"pone.0352514.ref064","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41586-023-06957-x","article-title":"Genomic data in the All of Us Research Program","volume":"627","author":"The All of Us Research Program Genomics Investigators","year":"2024","journal-title":"Nature"},{"issue":"1","key":"pone.0352514.ref065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12859-024-05715-8","article-title":"Few-shot genes selection: subset of PAM50 genes for breast cancer subtypes classification","volume":"25","author":"LYS Okimoto","year":"2024","journal-title":"BMC Bioinform"},{"issue":"6","key":"pone.0352514.ref066","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.7150\/jca.37637","article-title":"Tumour-infiltrating immune cell-based subtyping and signature gene analysis in breast cancer based on gene expression profiles","volume":"11","author":"J Jiang","year":"2020","journal-title":"J Cancer"},{"issue":"2","key":"pone.0352514.ref067","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1134\/S1068162023020139","article-title":"Drug repurposing: an effective tool in modern drug discovery","volume":"49","author":"VS Kulkarni","year":"2023","journal-title":"Russ J Bioorg Chem"},{"issue":"7","key":"pone.0352514.ref068","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3390\/pharmaceutics15071796","article-title":"Triple negative breast cancer treatment options and limitations: future outlook","volume":"15","author":"O Obidiro","year":"2023","journal-title":"Pharmaceutics"},{"issue":"8","key":"pone.0352514.ref069","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype","volume":"37","author":"D Kim","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"16","key":"pone.0352514.ref070","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"H Li","year":"2009","journal-title":"Bioinformatics"},{"key":"pone.0352514.ref071","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"The 1000 Genomes Project Consortium","year":"2015","journal-title":"Nature"},{"issue":"22","key":"pone.0352514.ref072","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1093\/bioinformatics\/btz275","article-title":"NGSEP3: accurate variant calling across species and sequencing protocols","volume":"35","author":"D Tello","year":"2019","journal-title":"Bioinformatics"},{"issue":"15","key":"pone.0352514.ref073","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/bioinformatics\/btr330","article-title":"The variant call format and VCFtools","volume":"27","author":"P Danecek","year":"2011","journal-title":"Bioinformatics"},{"key":"pone.0352514.ref074","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","article-title":"Second-generation PLINK: rising to the challenge of larger and richer datasets","volume":"4","author":"CC Chang","year":"2015","journal-title":"Gigascience"},{"issue":"9","key":"pone.0352514.ref075","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1101\/gr.094052.109","article-title":"Fast model-based estimation of ancestry in unrelated individuals","volume":"19","author":"DH Alexander","year":"2009","journal-title":"Genome Res"},{"issue":"3","key":"pone.0352514.ref076","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nbt.3122","article-title":"StringTie enables improved reconstruction of a transcriptome from RNA-seq reads","volume":"33","author":"M Pertea","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"12","key":"pone.0352514.ref077","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"MI Love","year":"2014","journal-title":"Genome Biol"},{"issue":"3","key":"pone.0352514.ref078","article-title":"ComBat-seq: batch effect adjustment for RNA-seq count data","volume":"2","author":"Y Zhang","year":"2020","journal-title":"NAR Genom Bioinform"},{"issue":"7","key":"pone.0352514.ref079","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/bioinformatics\/btv693","article-title":"Genefu: an R\/Bioconductor package for computation of gene expression-based signatures in breast cancer","volume":"32","author":"DMA Gendoo","year":"2016","journal-title":"Bioinformatics"},{"key":"pone.0352514.ref080","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkad347","article-title":"g:Profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update)","volume":"51","author":"L Kolberg","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"pone.0352514.ref081","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant graphics for data analysis","author":"H Wickham","year":"2016"},{"issue":"9","key":"pone.0352514.ref082","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels","volume":"9","author":"P Geeleher","year":"2014","journal-title":"PLoS One"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0352514","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:33:51Z","timestamp":1784914431000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0352514"}},"subtitle":[],"editor":[{"given":"Alexis G. Murillo","family":"Carrasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":82,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0352514","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]}}}